CAS: 1562993-37-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ponatinib-d8 REF: 4Z-P-123002CAS: 1562993-37-6 | - - - | To inquire | Tue 19 Nov 24 |
 | Ponatinib-d8 REF: TM-T12521CAS: 1562993-37-6 | 98% | To inquire | Thu 21 Nov 24 |
 | Ponatinib-d8 REF: TR-P688252CAS: 1562993-37-6 | - - - | 345.00 €~2,640.00 € | Fri 29 Nov 24 |
 | Ponatinib d8 REF: 3D-MMC99337CAS: 1562993-37-6 | Min. 95% | - - - | Discontinued product |
Ponatinib-d8
CAS:1562993-37-6
Formula:
C29H19D8F3N6O
Color and Shape:
Pale Yellow Solid
Molecular weight:
540.62
Ref: 4Z-P-123002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 19 Nov 2024
Ponatinib-d8
CAS:1562993-37-6
Ponatinib D8 is a deuterium-enriched, oral multi-kinase inhibitor (Abl, PDGFRα, VEGFR2, FGFR1, Src; IC50s: 0.37-5.4 …
Formula:
C29H27F3N6O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
540.61
Ref: TM-T12521
| 1mg | 262.00 € | ||
| 5mg | 638.00 € |
Estimated delivery in United States, on Thursday 21 Nov 2024
Ponatinib-d8
Controlled ProductCAS:1562993-37-6
Applications Ponatinib-d8 is an isotope labelled compound of Ponatinib (P688250). Ponatinib is a tyrosine kinase …
Formula:
C29H19D8F3N6O
Color and Shape:
Neat
Molecular weight:
540.61
Ref: TR-P688252
| 1mg | 345.00 € | ||
| 5mg | 1,331.00 € | ||
| 10mg | 2,640.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Ponatinib d8
CAS:1562993-37-6
Please enquire for more information about Ponatinib d8 including the price, delivery time and more …
Formula:
C29H27F3N6O
Purity:
Min. 95%
Molecular weight:
540.6 g/mol
Ref: 3D-MMC99337
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
